Associação Hospital de Caridade Ijuí

Ijuí, Rio Grande do Sul 98700-000

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma

Studies at this site

• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early